Sobel RE - Search Results

1

Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular events.

Sobel RE, Reynolds RF. Sobel RE, et al. Curr Med Res Opin. 2008 Jul;24(7):1861-8. doi: 10.1185/03007990802128781. Epub 2008 May 27. Curr Med Res Opin. 2008. PMID: 18507892

2

Cardiovascular outcomes among sildenafil users: results of the International Men's Health Study.

Mittleman MA, Maclure M, Lewis MA, Hall GC, Moore N, Giuliano F, Porst H, Hedelin H, Martin-Morales A, Sobel RE, Reynolds R, Glasser DB. Mittleman MA, et al. Among authors: sobel re. Int J Clin Pract. 2008 Mar;62(3):367-73. doi: 10.1111/j.1742-1241.2007.01679.x. Int J Clin Pract. 2008. PMID: 18261073

3

Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools.

Sobel RE, Bate A, Marshall J, Haynes K, Selvam N, Nair V, Daniel G, Brown JS, Reynolds RF. Sobel RE, et al. Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):332-339. doi: 10.1002/pds.4392. Epub 2018 Feb 2. Pharmacoepidemiol Drug Saf. 2018. PMID: 29392851

4

Real World Evidence: Time for a Switch?

Sobel RE, Bate A, Reynolds RF. Sobel RE, et al. Drug Saf. 2018 Dec;41(12):1309-1312. doi: 10.1007/s40264-018-0739-y. Drug Saf. 2018. PMID: 30302624 No abstract available.

5

Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.

Sobel RE, Lovell DJ, Brunner HI, Weiss JE, Morris PW, Gottlieb BS, Chalom EC, Jung LK, Onel KB, Petiniot L, Goldsmith DP, Nanda K, Shishov M, Abramsky S, Young JP, Giannini EH; Pediatric Rheumatology Collaborative Study Group. Sobel RE, et al. Pediatr Rheumatol Online J. 2014 Jul 16;12:29. doi: 10.1186/1546-0096-12-29. eCollection 2014. Pediatr Rheumatol Online J. 2014. PMID: 25057265 Free PMC article.

6

Computer-assisted expert case definition in electronic health records.

Walker AM, Zhou X, Ananthakrishnan AN, Weiss LS, Shen R, Sobel RE, Bate A, Reynolds RF. Walker AM, et al. Among authors: sobel re. Int J Med Inform. 2016 Feb;86:62-70. doi: 10.1016/j.ijmedinf.2015.10.005. Epub 2015 Oct 31. Int J Med Inform. 2016. PMID: 26725697

7

Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.

Gorkin L, Hvidsten K, Sobel RE, Siegel R. Gorkin L, et al. Among authors: sobel re. Int J Clin Pract. 2006 Apr;60(4):500-3. doi: 10.1111/j.1368-5031.2006.00904.x. Int J Clin Pract. 2006. PMID: 16620369 Free PMC article.

8

A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect^® additional risk minimisation measures.

Lem J, Collins J, Maguire T, Sobel RE. Lem J, et al. Among authors: sobel re. Int J Clin Pharm. 2022 Jun;44(3):608-618. doi: 10.1007/s11096-021-01339-7. Epub 2022 Apr 5. Int J Clin Pharm. 2022. PMID: 35380395 Free PMC article.

9

Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database.

Asomaning K, Abramsky S, Liu Q, Zhou X, Sobel RE, Watt S. Asomaning K, et al. Among authors: sobel re. Int J Clin Pract. 2016 May;70(5):380-8. doi: 10.1111/ijcp.12791. Epub 2016 Mar 29. Int J Clin Pract. 2016. PMID: 27028939

10

Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.

Lem J, Younus M, Aram JA, Moosavi S, Freivogel K, Lewis A, Sobel RE. Lem J, et al. Among authors: sobel re. Pharmaceut Med. 2019 Apr;33(2):121-133. doi: 10.1007/s40290-019-00273-4. Pharmaceut Med. 2019. PMID: 31933256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters